# Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

> **NCT01377974** · PHASE2 · COMPLETED · sponsor: **Brasilia University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Leishmaniasis
- Leishmaniasis, Mucocutaneous

## Interventions

- **DRUG:** Miltefosine
- **DRUG:** Standard Treatment Meglumine antimoniate

## Key facts

- **NCT ID:** NCT01377974
- **Lead sponsor:** Brasilia University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2013-06
- **Final completion:** 2014-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377974, "Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01377974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*